folder

SMARCAD1 haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility

Authors

  • C. Günther
  • M.A. Lee-Kirsch
  • J. Eckhard
  • A. Matanovic
  • T. Kerscher
  • F. Rüschendorf
  • B. Klein
  • N. Berndt
  • N. Zimmermann
  • C. Flachmeier
  • T. Thuß
  • N. Lucas
  • I. Marenholz
  • J. Esparza-Gordillo
  • N. Hübner
  • H. Traupe
  • E. Delaporte
  • Y.A. Lee

Journal

  • Journal of Investigative Dermatology

Citation

  • J Invest Dermatol 138 (6): 1428-1431

Abstract

  • Huriez syndrome is a rare dominant genodermatosis characterized by congenital palmoplantar keratosis, scleroatrophic changes of the hands and feet, and an increased risk for cutaneous squamous cell carcinoma (CSCC) in approximately 15% of affected individuals (Figure 1a, Supplementary Table S1 online). CSCC in Huriez syndrome is characterized by early onset, localization on scleroatrophic skin, and aggressive metastasis formation (Delaporte et al., 1995; Hamm et al., 1996) suggesting that the local disease-specific skin changes promote malignant transformation.


DOI

doi:10.1016/j.jid.2018.01.015